The National Pharmaceutical Pricing Authority (NPPA) has issued notices, during 2015-16, to 263 pharma firms, which were found overcharging for their products, parliament was told on Tuesday.
The NPPA issued demand notices to 263 companies amounting to Rs.928.32 crore during the last fiscal, and recoveries effected are to the tune of Rs.12.68 crore, Minister of State for Chemicals and Fertilisers Hansraj Gangaram Ahir told the Lok Sabha in a written reply.
"Whenever companies are found overcharging the consumer in respect to price of medicines, NPPA issues demand notices for recovery of overcharged amount along with interest thereon under various provisions of DPCO (Drugs Price Contrl Order) 1995 and DPCO 2013," he said.
"The ceiling price of scheduled medicines are fixed by NPPA on market-based methodology. The companies are not allowed to increase the price beyond wholesale price index in a year," he added.
--IANS
bc/vd
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
